235 Results

People

  1. Zelenetz
    Zelenetz
  2. Salles
    Salles
  3. Palomba
    Palomba
  4. Chaganti
    Chaganti
  5. Dogan
    Dogan
  6. Matasar
    Matasar
  7. Offit
    Offit
  8. Younes
    Younes
  9. Batlevi
    Batlevi
  10. Portlock
    Portlock

Groups

  1. Department of Medicine (169)
  2. Hematologic Malignancies, Division of (153)
  3. Center for Hematologic Malignancies (130)
  4. Lymphoma (103)
  5. Survivorship Research (52)
  6. GSK Faculty (43)
  7. Sloan Kettering Institute Postdocs (31)
  8. Population Sciences Research Program (28)
  9. Department of Pathology and Laboratory Medicine (27)
  10. Epidemiology and Biostatistics (22)
  1. "follicular lymphoma"
Formats
  1. Journal Article (188)
  2. Review (17)
  3. Meeting Abstract (8)
  4. Editorial (5)
  5. Research Letter (5)
  6. Correspondence (4)
  7. Guidelines (4)
  8. Conference Paper (3)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (169)
  2. Hematologic Malignancies, Division of (153)
  3. Center for Hematologic Malignancies (130)
  4. Lymphoma (103)
  5. Survivorship Research (52)
  6. GSK Faculty (43)

More Groups

People
  1. Andrew Zelenetz (45)
  2. Gilles Salles (24)
  3. Maria Palomba (19)
  4. Ahmet Dogan (13)
  5. Anas Younes (13)
  6. Kenneth Offit (13)

More People

Years
  1. 2025 (11)
  2. 2024 (21)
  3. 2023 (23)
  4. 2022 (18)
  5. 2021 (14)
  6. 2020 (15)

More Years

Publications
  1. Leukemia and Lymphoma (19)
  2. Clinical Lymphoma, Myeloma and Leukemia (11)
  3. Blood (10)
  4. Journal of Clinical Oncology (10)
  5. British Journal of Haematology (9)
  6. Blood Advances (8)

More Publications

Publishers
  1. Elsevier Inc. (32)
  2. Taylor & Francis Group (21)
  3. American Society of Hematology (18)
  4. Nature Publishing Group (17)
  5. Springer (13)
  6. John Wiley & Sons (12)

More Publishers

Results (235)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ibrutinib associated with rituximab-platinum salt-based immunochemotherapy in B-cell lymphomas: Results of a phase 1b-II study of the LYSA group
    Journal Article

    Bonnet, C.; Dupuis, J.; Tilly, H.; Lamy, T.; Fruchart, C.; le Gouill, S.; Thieblemont, C.; Morschhauser, F.; Casasnovas, O.; Bouabdallah, K.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Chemotherapy-free regimens in frontline follicular lymphoma
    Editorial

    Batlevi, C. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
    Journal Article

    Moore, A.; Machiela, M. J.; Machado, M.; Wang, S. S.; Kane, E.; Slager, S. L.; Zhou, W.; Carrington, M.; Lan, Q.; Milne, R. L.; more...
    Journal of Translational Genetics and Genomics (2021)

    Fulltext@MSK | Save
  • Genomic studies indicate a novel combination therapy for follicular lymphoma
    Journal Article

    Oricchio, E.; Wendel, H. G.
    Molecular and Cellular Oncology (2021)

    Fulltext@MSK | Save
  • Idelalisib immune-related toxicity is associated with improved treatment response
    Journal Article

    Wagner-Johnston, N. D.; Sharman, J.; Furman, R. R.; Salles, G.; Brown, J. R.; Robak, T.; Gu, L.; Xing, G.; Chan, R. J.; Rajakumaraswamy, N.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
    Journal Article

    Mou, E.; Falchi, L.; Sundaram, V.; Abramson, J. S.; Balassanian, R.; Beygi, S.; Fitzpatrick, M. J.; Frank, A. K.; Gupta, S.; Lin, O.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials
    Journal Article

    Palomba, M. L.; Jun, M. P.; Lymp, J.; Nguyen, A.; McGarvey, N.; Gitlin, M.; Pelletier, C.; Keating, S. J.; Godwin, J.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Updated experience from mosunetuzumab in multiple relapsed follicular lymphoma: Promising efficacy from a phase I trial
    Meeting Abstract

    Assouline, S.; Kim, W. S.; Sehn, L. H.; Schuster, S. J.; Cheah, C. Y.; Nastoupil, L. J.; Shadman, M.; Yoon, S. S.; Matasar, M. J.; Diefenbach, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save